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138 COOH groups in the presence of pyridine.
139
IONP-NH 2 nanoparticles and the activated IONP-COOH were mixed at a ratio of 2.5:1 and 140 allowed to react for 30 min. The reaction was then arrested by 'deactivating' the carboxyl groups 141 using a 10-molar excess of ethylenediamine (relative to the number of carboxyl groups). Finally, 142 nanochains were transferred to water and were separated by centrifugation with Amicon ® Ultra-143 15 centrifugal filters. To further clean nanochains from any unreacted parent nanoparticles, a 144 strong magnet was used.
Functionalization of Nanoparticles with Targeting Ligands

146
Functionalization of nanoparticles with vascular targeting ligands was accomplished via a 147 sulfo-SMCC crosslinker. The nanoparticle composites, IONP-NH 2 and NC-NH 2 , had terminal 148 amine groups that are readily available for conjugation with available thiol groups on the cysteine 149 end of the targeting ligands. Here P-selectin-targeting peptide CDAEWVDVS and fibrin-targeting 150 peptide CREKA were used. Briefly, sulfo-SMCC contains two functional terminal groups on 151 contralateral sides; an amine-reactive N-hydroxysuccinimide (NHS ester) and a sulfhydryl-152 reactive maleimide group. First, sulfo-SMCC in a 2-molar excess to available amine groups on 153 the IONP-NH 2 solution and allowed to react for 30 minutes while shaking. Next, a 2:3 molar excess 154 of sulfo-SMCC to targeting ligand was added and allowed to react for an additional 2 hours while 155 shaking. The functionalized product was dialyzed against PBS using a 100,000 Da MW cut-off 156 dialysis bag to remove excess peptide and crosslinker. For dual-ligand functionalization equal 157 molar peptides were added with the overall molar excess to sulfo-SMCC still at a 2:3 molar ratio 158 (2-moles sulfo-SMCC:1.5 moles fibrin-targeting peptide:1.5 moles P-selectin targeting peptide).
159
Bio-Rad DC protein assay was used to quantify the total number of conjugated peptides.
160 Here, 200 µL of Bio-Rad dye solution (1 to 2 parts Bio-Rad dye and water) was added to an 800 161 µL solution of 10 mg/mL particles and vortexed. The absorbance of the sample was obtained at 162 595 nm after incubating the sample for 15 minutes. The absorbance value was compared to a 163 standard curve, which was obtained by measuring the known absorbance of known 164 concentrations of CREKA, P-selectin peptide or both. 179 studies were performed on a similar timeline. The animals were closely monitored on a daily basis 180 to ensure they did not suffer adverse effects resulting from tumor inoculations.
181
The well-being of the animals took priority over precise measurements in decisions 182 regarding euthanasia or other interventions. All procedures were conducted using anesthetic to 183 minimize pain and distress. The inhalant anesthetic, isoflurane, was used as the primary 184 anesthesia in our experiments. However, developing tumors may ultimately result in some level 185 of distress or discomfort in these mice. If, during the time following tumor inoculation the animal 186 showed signs of post-procedure pain, the animal was euthanized. The research team, as well as 187 the veterinary team of the animal facility, diligently monitored the condition of the animals, and 
244
To determine the detection accuracy of particle conjugates z-score probabilities values 245 were obtained to evaluate the effective belonginess of a single particle conjugate member to a 246 healthy mammary fat pad population. The z-score probabilities were obtained via a confidence 247 interval of 90% ( was set to 0.1). If a population member fell inside of the 90% confidence interval 248 it was considered to be part of the healthy mammary fat pad population; these members were 249 considered to be false negatives as the tumors were present however the p-values indicated they 250 fell in the healthy population.
RESULTS
Nanoparticle Fabrication
253
We recently developed a new simple 'one-pot' synthetic concept for making iron oxide 254 nanochains with high yield and consistency [13] . Fig 1a shows an illustration of the nanochain 255 particles. Briefly, the one-pot synthesis utilized two types of the parent iron oxide nanoparticle 256 (IONP) based on the functional group on the particle's surface (Fig 1b) . The IONP were decorated 257 with either PEG-amine (NP-NH 2 ) or PEG-carboxyl (NP-COOH). First, the carboxyl groups on the 258 NP-COOH particles were activated with DCC. To avoid hydrolysis of the activated COOH 259 intermediate, the one-pot synthesis was performed in an organic solvent (i.e., absence of water).
260 Once activated NP-COOH and NP-NH 2 were mixed, the nanoparticles started reacting with each 261 other. The reaction rate and size of the agglomerates can be dictated by the stirring rate, 262 stoichiometry and concentration of the starting IONP particles. By mixing NP-NH 2 and NP-COOH 263 at a ratio of ~2:1, two NP-NH 2 particles were initially linked with one 'activated' NP-COOH forming 264 a trimeric nanochain. We identified the optimal reaction time and parameters that generated well- 299 However, the MR signal from tissues does not always correspond to the exact concentration of 300 the iron oxide particles in tissues. Iron oxide particles exhibit complex relaxation properties in vivo, 301 which is significantly influenced by iron clustering in the case of intracellular internalization of the 302 nanoparticles. Since the intended use of the dual-ligand nanochain is as an MR imaging agent, 303 we elected to measure the R2 relaxation rate in tissue as a surrogate metric of MR signal with 304 higher R2 value indicating stronger signal. Briefly, 3 h after injection of the nanoparticles, mice 305 were transcardially perfused with PBS and each organ was excised and homogenized. The 306 relaxation of samples of the homogenate was measured using a 1.5 T Bruker Minispec and was 307 recorded as tissue relaxivity per gram of tissue. This provided a robust method to measure 308 multiple samples in a convenient and quantitative manner. Fig 2 shows a comparison of the organ 309 distribution of the different nanoparticle variants. We tested dual-ligand nanochains targeting
